Ferguson James J. III — SEC Form 4 filings

SEC reporting owner CIK 1769041. 3 Form 4 filings on record with FilingPulse; latest filed 2026-08-12.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2023-12-15 to 2026-08-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Mineralys Therapeutics, Inc. (MLYS)Chief Medical Officer12
Cadrenal Therapeutics, Inc. (CVKD)Chief Medical Officer11
Matinas BioPharma Holdings, Inc. (MTNB)Chief Medical Officer11

Form 4 filings — Ferguson James J. III

FiledFormIssuerReported transactionsSource
2026-08-124Mineralys Therapeutics, Inc. (MLYS)Grant/award (A): 102,400 @ $0 · Grant/award (A): 135,000 (derivative) @ $0EDGAR
2025-02-064Cadrenal Therapeutics, Inc. (CVKD)Grant/award (A): 60,000 (derivative) @ $0EDGAR
2023-12-154Matinas BioPharma Holdings, Inc. (MTNB)Grant/award (A): 1,200,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2023-12-15 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1769041 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →